Jan Stenvang

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Colorectal Neoplasms 95%
3. Irinotecan 77%
4. MicroRNAs 71%
5. Biomarkers 59%
6. locked nucleic acid 56%
7. Tissue Inhibitor of Metalloproteinase-1 55%
8. Cell Line 49%
9. 1-(3-C-ethynylribopentofuranosyl)cytosine 47%
10. Oxaliplatin 45%
11. Neoplasms 37%
12. 1-(3-C-ethynylribopentofuranosyl)uracil 35%
13. Proteins 34%
14. Docetaxel 26%
15. Genes 26%
16. Gene Dosage 24%
17. Progesterone Receptors 24%
18. Pharmaceutical Preparations 24%
19. Type I DNA Topoisomerase 22%
20. Drug Therapy 22%
21. Therapeutics 22%
22. Drug Resistance 22%
23. Estrogen Receptor Modulators 20%
24. DNA Methylation 20%
25. Gene Expression 19%
26. Paraffin 19%
27. Formaldehyde 18%
28. Oligonucleotides 18%
29. Tamoxifen 17%
30. Anthracyclines 16%
31. Nucleosides 16%
32. Colonic Neoplasms 15%
33. Messenger RNA 15%
34. MCF-7 Cells 15%